Kelly L. Moore

3.3k total citations · 2 hit papers
45 papers, 2.2k citations indexed

About

Kelly L. Moore is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Kelly L. Moore has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 13 papers in Health and 9 papers in Infectious Diseases. Recurrent topics in Kelly L. Moore's work include Vaccine Coverage and Hesitancy (11 papers), Virology and Viral Diseases (7 papers) and Hepatitis B Virus Studies (6 papers). Kelly L. Moore is often cited by papers focused on Vaccine Coverage and Hesitancy (11 papers), Virology and Viral Diseases (7 papers) and Hepatitis B Virus Studies (6 papers). Kelly L. Moore collaborates with scholars based in United States, United Kingdom and Switzerland. Kelly L. Moore's co-authors include Manisha Patel, Mark J. van der Laan, Janice B. Schwartz, Kathleen Dooling, Grace M. Lee, Rafael Harpaz, Angela Guo, Edward A. Belongia, W. John Boscardin and Michael A. Steinman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kelly L. Moore

44 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

2018 434 citations Kathleen Dooling, Angela Guo et al. MMWR Morbidity and Mortality Weekly Report profile →
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

2022 110 citations Mark K. Weng, Mona Doshani et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly L. Moore United States	23	1.1k	422	360	322	203	45	2.2k
Karen J. Goodman Canada	34	751 0.7×	663 1.6×	93 0.3×	168 0.5×	185 0.9×	128	4.7k
Anthony T. Newall Australia	29	1.8k 1.7×	646 1.5×	530 1.5×	129 0.4×	319 1.6×	102	3.1k
David W. Hutton United States	28	1.1k 1.0×	261 0.6×	94 0.3×	686 2.1×	200 1.0×	136	2.8k
Shally Awasthi India	36	1.0k 1.0×	420 1.0×	439 1.2×	76 0.2×	656 3.2×	215	4.6k
Philip Smith United States	25	731 0.7×	910 2.2×	200 0.6×	38 0.1×	260 1.3×	70	1.7k
Georgios K. Nikolopoulos Greece	38	2.0k 1.9×	1.4k 3.3×	139 0.4×	347 1.1×	453 2.2×	212	4.9k
Erik J. Dasbach United States	30	2.4k 2.2×	515 1.2×	378 1.1×	53 0.2×	376 1.9×	66	4.4k
Antoni Trilla Spain	30	863 0.8×	763 1.8×	240 0.7×	46 0.1×	274 1.3×	143	3.2k
Richard H. Morrow United States	28	607 0.6×	422 1.0×	110 0.3×	85 0.3×	302 1.5×	66	2.6k
Theodore Lytras Greece	29	1.1k 1.0×	793 1.9×	213 0.6×	60 0.2×	156 0.8×	70	3.3k

Countries citing papers authored by Kelly L. Moore

Since Specialization

Citations

This map shows the geographic impact of Kelly L. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly L. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly L. Moore more than expected).

Fields of papers citing papers by Kelly L. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly L. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly L. Moore. The network helps show where Kelly L. Moore may publish in the future.

Co-authorship network of co-authors of Kelly L. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly L. Moore. A scholar is included among the top collaborators of Kelly L. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly L. Moore. Kelly L. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, H. Nina, Kelly L. Moore, David L. Sanders, et al.. (2024). Implementing Adult Hepatitis B Immunization and Screening Using Electronic Health Records: A Practical Guide. Vaccines. 12(5). 536–536. 1 indexed citations

Weng, Mark K., Mona Doshani, Mohammed A. Khan, et al.. (2022). Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR Morbidity and Mortality Weekly Report. 71(13). 477–483. 110 indexed citations breakdown →

Weng, Mark K., Mona Doshani, Mohammed A. Khan, et al.. (2022). Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022. American Journal of Transplantation. 22(6). 1714–1720. 10 indexed citations

Giersing, Birgitte, Martin I. Meltzer, Anna-Léa Kahn, et al.. (2021). The CAPACITI Decision-Support Tool for National Immunization Programs. Value in Health. 24(8). 1150–1157. 15 indexed citations

Kartoğlu, Ümit, Kelly L. Moore, & John Lloyd. (2020). Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers. Vaccine. 38(34). 5393–5395. 27 indexed citations

Maron, Steven B., Leah M. Chase, Samantha Lomnicki, et al.. (2019). Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma. Clinical Cancer Research. 25(23). 7098–7112. 147 indexed citations

Marlow, Mariel, Mona Marin, Kelly L. Moore, & Manisha Patel. (2019). CDC Guidance for Use of a Third Dose of MMR Vaccine During Mumps Outbreaks. Journal of Public Health Management and Practice. 26(2). 109–115. 21 indexed citations

Dooling, Kathleen, Angela Guo, Manisha Patel, et al.. (2018). Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. American Journal of Transplantation. 18(3). 756–762. 43 indexed citations

Dooling, Kathleen, Angela Guo, Manisha Patel, et al.. (2018). Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines. MMWR Morbidity and Mortality Weekly Report. 67(3). 103–108. 434 indexed citations breakdown →

10.

Williams, S., et al.. (2014). Evaluation of the feasibility of a state-based vaccine safety advice network. Vaccine. 32(8). 901–903. 1 indexed citations

11.

Tan, Litjen, Melissa A. Barnett, Jesse M. Hackell, et al.. (2014). From refrigerator to arm: Issues in vaccination delivery. Vaccine. 32(21). 2389–2393. 12 indexed citations

12.

Moore, Kelly L., W. John Boscardin, Michael A. Steinman, & Janice B. Schwartz. (2014). Patterns of chronic co-morbid medical conditions in older residents of U.S. nursing homes: Differences between the sexes and across the agespan. The journal of nutrition health & aging. 18(4). 429–436. 82 indexed citations

13.

Kane, L., Kelly L. Moore, Dieter Lütjohann, Daniel D. Bikle, & Janice B. Schwartz. (2013). Vitamin D3 Effects on Lipids Differ in Statin and Non-Statin-Treated Humans: Superiority of Free 25-OH D Levels in Detecting Relationships. The Journal of Clinical Endocrinology & Metabolism. 98(11). 4400–4409. 35 indexed citations

14.

Schwartz, Janice B., L. Kane, Kelly L. Moore, & Alan H.B. Wu. (2011). Failure of Pharmacogenetic-based Dosing Algorithms to Identify Older Patients Requiring Low Daily Doses of Warfarin. Journal of the American Medical Directors Association. 12(9). 633–638. 16 indexed citations

15.

Moore, Kelly L., Romain Neugebauer, Thamban Valappil, & Mark J. van der Laan. (2011). Robust extraction of covariate information to improve estimation efficiency in randomized trials. Statistics in Medicine. 30(19). 2389–2408. 21 indexed citations

16.

Moore, Kelly L.. (2009). Targeted maximum likelihood estimation of treatment effects in randomized controlled trials and drug safety analysis. eScholarship (California Digital Library).

17.

Moore, Kelly L., et al.. (2008). Ambient Ozone Concentrations Cause Increased Hospitalizations for Asthma in Children: An 18-Year Study in Southern California. Environmental Health Perspectives. 116(8). 1063–1070. 67 indexed citations

18.

Moore, Kelly L. & Mark J. van der Laan. (2008). Covariate adjustment in randomized trials with binary outcomes: Targeted maximum likelihood estimation. Statistics in Medicine. 28(1). 39–64. 124 indexed citations

19.

Eisenberg, Joseph N. S., et al.. (2008). Microbial Risk Assessment Framework for Exposure to Amended Sludge Projects. Environmental Health Perspectives. 116(6). 727–733. 40 indexed citations

20.

Moore, Kelly L., Marion Kainer, Nadia Badrawi, et al.. (2005). Neonatal Sepsis in Egypt Associated With Bacterial Contamination of Glucose-Containing Intravenous Fluids. The Pediatric Infectious Disease Journal. 24(7). 590–594. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact